Price T Rowe Associates Inc. MD Buys 2,261,046 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Price T Rowe Associates Inc. MD raised its stake in shares of Celsius Holdings, Inc. (NASDAQ:CELHFree Report) by 424.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,793,210 shares of the company’s stock after buying an additional 2,261,046 shares during the period. Price T Rowe Associates Inc. MD owned about 1.21% of Celsius worth $152,287,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CELH. Eagle Asset Management Inc. raised its stake in Celsius by 188.8% during the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after buying an additional 1,934,400 shares during the last quarter. Artisan Partners Limited Partnership bought a new position in Celsius in the 4th quarter worth $101,116,000. Capital International Investors boosted its holdings in Celsius by 200.0% in the 4th quarter. Capital International Investors now owns 2,632,977 shares of the company’s stock worth $143,550,000 after buying an additional 1,755,318 shares during the period. Norges Bank bought a new position in Celsius in the 4th quarter worth $85,141,000. Finally, Stephens Investment Management Group LLC boosted its holdings in Celsius by 194.0% in the 4th quarter. Stephens Investment Management Group LLC now owns 2,081,208 shares of the company’s stock worth $113,467,000 after buying an additional 1,373,261 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Trading Down 3.4 %

Shares of NASDAQ:CELH traded down $2.09 on Friday, hitting $59.96. 5,203,348 shares of the company were exchanged, compared to its average volume of 4,922,623. Celsius Holdings, Inc. has a 1-year low of $45.03 and a 1-year high of $99.62. The stock’s 50 day moving average price is $78.94 and its 200 day moving average price is $69.41. The firm has a market capitalization of $13.98 billion, a P/E ratio of 68.19, a price-to-earnings-growth ratio of 1.72 and a beta of 1.93.

Celsius (NASDAQ:CELHGet Free Report) last issued its earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.07. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The firm had revenue of $355.70 million during the quarter, compared to analysts’ expectations of $390.37 million. During the same quarter last year, the company posted $0.13 earnings per share. The firm’s revenue was up 36.9% compared to the same quarter last year. On average, equities analysts predict that Celsius Holdings, Inc. will post 1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CELH has been the subject of several research reports. Bank of America increased their price objective on shares of Celsius from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, May 29th. Morgan Stanley decreased their target price on shares of Celsius from $75.00 to $68.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Stifel Europe upped their target price on shares of Celsius from $90.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 18th. Wedbush decreased their target price on shares of Celsius from $85.00 to $83.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Roth Mkm upped their target price on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, March 14th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $87.56.

View Our Latest Report on CELH

Insider Buying and Selling at Celsius

In other news, major shareholder William H. Milmoe sold 428,568 shares of Celsius stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $59.67, for a total value of $25,572,652.56. Following the sale, the insider now owns 25,464,453 shares in the company, valued at $1,519,463,910.51. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, major shareholder William H. Milmoe sold 428,568 shares of the business’s stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $59.67, for a total transaction of $25,572,652.56. Following the transaction, the insider now directly owns 25,464,453 shares in the company, valued at $1,519,463,910.51. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder William H. Milmoe sold 428,574 shares of the business’s stock in a transaction dated Friday, May 3rd. The stock was sold at an average price of $59.67, for a total transaction of $25,573,010.58. Following the transaction, the insider now owns 23,964,450 shares in the company, valued at $1,429,958,731.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,776,696 shares of company stock valued at $107,920,209. Corporate insiders own 2.20% of the company’s stock.

Celsius Profile

(Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Stories

Want to see what other hedge funds are holding CELH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celsius Holdings, Inc. (NASDAQ:CELHFree Report).

Institutional Ownership by Quarter for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.